These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 37781379)

  • 1. Advances in phage display based nano immunosensors for cholera toxin.
    Li Y; Yang KD; Kong DC; Ye JF
    Front Immunol; 2023; 14():1224397. PubMed ID: 37781379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant
    Hays SG; Seed KD
    Elife; 2020 Apr; 9():. PubMed ID: 32329714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and environmental isolates of Vibrio cholerae serogroup O141 carry the CTX phage and the genes encoding the toxin-coregulated pili.
    Dalsgaard A; Serichantalergs O; Forslund A; Lin W; Mekalanos J; Mintz E; Shimada T; Wells JG
    J Clin Microbiol; 2001 Nov; 39(11):4086-92. PubMed ID: 11682534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vibrio cholerae infection, novel drug targets and phage therapy.
    Fazil MH; Singh DV
    Future Microbiol; 2011 Oct; 6(10):1199-208. PubMed ID: 22004038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism of acquisition of the cholera toxin genes.
    Das B; Bischerour J; Barre FX
    Indian J Med Res; 2011 Feb; 133(2):195-200. PubMed ID: 21415494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative genomic analyses of the vibrio pathogenicity island and cholera toxin prophage regions in nonepidemic serogroup strains of Vibrio cholerae.
    Li M; Kotetishvili M; Chen Y; Sozhamannan S
    Appl Environ Microbiol; 2003 Mar; 69(3):1728-38. PubMed ID: 12620865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysogenic conversion by a filamentous phage encoding cholera toxin.
    Waldor MK; Mekalanos JJ
    Science; 1996 Jun; 272(5270):1910-4. PubMed ID: 8658163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The
    Gutierrez-Rodarte M; Kolappan S; Burrell BA; Craig L
    J Biol Chem; 2019 Oct; 294(43):15698-15710. PubMed ID: 31471320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic control of Vibrio cholerae pathogenicity: the temperate filamentous phage CTX, coding for cholera toxin and the "island of pathogenicity"].
    Smirnova NI
    Mol Gen Mikrobiol Virusol; 1999; (4):3-11. PubMed ID: 10621931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemolytic Vibrio cholerae O1 that is sensitive to Mukerjee's cholera phage IV and the phage produced by the hemolytic vibrio lysogenized with the infection of Mukerjee's cholera phage IV.
    Iwanaga M; Nakamura S; Kuyyakanond T
    Microbiol Immunol; 1989; 33(8):609-18. PubMed ID: 2779469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Vibrio cholerae genome sequences reveals unique rtxA variants in environmental strains and an rtxA-null mutation in recent altered El Tor isolates.
    Dolores J; Satchell KJ
    mBio; 2013 Apr; 4(2):e00624. PubMed ID: 23592265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alteration of cholera toxin biosynthesis in Vibrio cholerae 01 as a result of temperate phage 139 integration into bacterial chromosome].
    Eroshenko GA; Smirnova NI
    Mol Gen Mikrobiol Virusol; 2002; (2):9-14. PubMed ID: 12180025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phage for treatment of Vibrio cholerae infection.
    Mittal M; Tripathi S; Saini A; Mani I
    Prog Mol Biol Transl Sci; 2023; 201():21-39. PubMed ID: 37770173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A molecular and epidemiological study of Vibrio cholerae isolates from cholera outbreaks in southern Ghana.
    Danso EK; Asare P; Otchere ID; Akyeh LM; Asante-Poku A; Aboagye SY; Osei-Wusu S; Opare D; Ntoumi F; Zumla A; Duodu S; Yeboah-Manu D
    PLoS One; 2020; 15(7):e0236016. PubMed ID: 32649692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of genes for virulence and ecological fitness among diverse Vibrio cholerae population in a cholera endemic area: tracking the evolution of pathogenic strains.
    Rahman MH; Biswas K; Hossain MA; Sack RB; Mekalanos JJ; Faruque SM
    DNA Cell Biol; 2008 Jul; 27(7):347-55. PubMed ID: 18462070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Type II Secretory System Mediates Phage Infection in
    Sun H; Liu M; Fan F; Li Z; Fan Y; Zhang J; Huang Y; Li Z; Li J; Xu J; Kan B
    Front Cell Infect Microbiol; 2021; 11():662344. PubMed ID: 33968805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolutionary Sweeps of Subviral Parasites and Their Phage Host Bring Unique Parasite Variants and Disappearance of a Phage CRISPR-Cas System.
    Angermeyer A; Hays SG; Nguyen MHT; Johura FT; Sultana M; Alam M; Seed KD
    mBio; 2021 Feb; 13(1):e0308821. PubMed ID: 35164562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of CTX and RS1 satellite phages genomic arrangement in Vibrio cholera toxin production in two recent cholera outbreaks (2012 and 2013) in IR Iran.
    Rezaie N; Bakhshi B; Najar-Peerayeh S
    Microb Pathog; 2017 Nov; 112():89-94. PubMed ID: 28923607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outer Membrane Vesicles of Vibrio cholerae Protect and Deliver Active Cholera Toxin to Host Cells via Porin-Dependent Uptake.
    Zingl FG; Thapa HB; Scharf M; Kohl P; Müller AM; Schild S
    mBio; 2021 Jun; 12(3):e0053421. PubMed ID: 34076466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage-bacterial interactions in the evolution of toxigenic Vibrio cholerae.
    Faruque SM; Mekalanos JJ
    Virulence; 2012 Nov; 3(7):556-65. PubMed ID: 23076327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.